What Are the Minimal Feeds Required for Starting Enteral Ibuprofen in Preterm Infants with PDA?

Ibuprofen is commonly used for the treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants. It seems that the oral formulation incurs a higher closure rate and has a better safety profile in preterm infants born > 26 weeks’ gestation. There is no consensus acros...

Descripción completa

Detalles Bibliográficos
Autores principales: Surak, Aimann, Hyderi, Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331810/
https://www.ncbi.nlm.nih.gov/pubmed/35894029
http://dx.doi.org/10.3390/pediatric14030040
_version_ 1784758493009412096
author Surak, Aimann
Hyderi, Abbas
author_facet Surak, Aimann
Hyderi, Abbas
author_sort Surak, Aimann
collection PubMed
description Ibuprofen is commonly used for the treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants. It seems that the oral formulation incurs a higher closure rate and has a better safety profile in preterm infants born > 26 weeks’ gestation. There is no consensus across Canadian centers regarding the minimum volume of enteral feeds required prior to starting ibuprofen for the treatment of patent ductus arteriosus, and the current practice is comfort-based depending on the centre and the local prevalence of neonatal morbidities.
format Online
Article
Text
id pubmed-9331810
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93318102022-07-29 What Are the Minimal Feeds Required for Starting Enteral Ibuprofen in Preterm Infants with PDA? Surak, Aimann Hyderi, Abbas Pediatr Rep Perspective Ibuprofen is commonly used for the treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants. It seems that the oral formulation incurs a higher closure rate and has a better safety profile in preterm infants born > 26 weeks’ gestation. There is no consensus across Canadian centers regarding the minimum volume of enteral feeds required prior to starting ibuprofen for the treatment of patent ductus arteriosus, and the current practice is comfort-based depending on the centre and the local prevalence of neonatal morbidities. MDPI 2022-07-24 /pmc/articles/PMC9331810/ /pubmed/35894029 http://dx.doi.org/10.3390/pediatric14030040 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Perspective
Surak, Aimann
Hyderi, Abbas
What Are the Minimal Feeds Required for Starting Enteral Ibuprofen in Preterm Infants with PDA?
title What Are the Minimal Feeds Required for Starting Enteral Ibuprofen in Preterm Infants with PDA?
title_full What Are the Minimal Feeds Required for Starting Enteral Ibuprofen in Preterm Infants with PDA?
title_fullStr What Are the Minimal Feeds Required for Starting Enteral Ibuprofen in Preterm Infants with PDA?
title_full_unstemmed What Are the Minimal Feeds Required for Starting Enteral Ibuprofen in Preterm Infants with PDA?
title_short What Are the Minimal Feeds Required for Starting Enteral Ibuprofen in Preterm Infants with PDA?
title_sort what are the minimal feeds required for starting enteral ibuprofen in preterm infants with pda?
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331810/
https://www.ncbi.nlm.nih.gov/pubmed/35894029
http://dx.doi.org/10.3390/pediatric14030040
work_keys_str_mv AT surakaimann whataretheminimalfeedsrequiredforstartingenteralibuprofeninpreterminfantswithpda
AT hyderiabbas whataretheminimalfeedsrequiredforstartingenteralibuprofeninpreterminfantswithpda

Ejemplares similares